| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 18,091 | 17,751 | 17,280 | 17,586 | | Cost of Revenue | 2,481 | 2,308 | 2,291 | 2,298 | | | Gross Profit |
-
| 15,443 | 14,989 | 15,288 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,014 | 8,646 | 8,050 | 7,435 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 8,300 | 19,200 | 1,500 | 1,050 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (12,403) | 5,439 | 6,803 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 296 | (12,403) | 5,439 | 6,803 | | Interest Expense | 784 | 860 | 817 | 1,052 | | Income Before Tax | (488) | (13,263) | 4,622 | 5,751 | | Income Tax Expense | (767) | (5,134) | 1,675 | 1,918 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 279 | (8,129) | 2,947 | 3,833 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 279 | (8,129) | 2,947 | 3,833 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $279 | ($8,129) | $2,947 | $3,833 |
|
1.52% Nasdaq 
Income Statement
